Results 141 to 150 of about 403,789 (225)

Availability of anti-rabies vaccine and rabies immunoglobulin in Indian health facilities: a nationwide cross-sectional health facility survey. [PDF]

Lancet Reg Health Southeast Asia
Krishna NS, Vivian Thangaraj JW, Devika S, Sasi A, Egambaram S, Rani DS, Khan SA, Delli A, Srivastava AK, Mishra A, Shrinivasa B, Pandiyan C, Gour D, Purakayastha DR, Verma N, Sharma P, Soni RK, Ramasamy S, Mohandas K S, Baidya S, Rehman T, Yeldandi VV, Singh A, Sreedevi A, Tandale BV, Durairajan C, Mahajan H, Jain K, Reddy MM, Toppo M, Solanki NV, Ghosh P, Vyas S, Das S, Palo SK, Prasanth V, Ali A, Bathin VG, Sahu DK, Rani GPS, Madhukar M, Zaman K, Pandey K, Chander MP, Kant R, Varkey RA, Pati S, Agarwal S, Panwar S, Menon VB, Vaman RS, Velayudhan A, Joy S, Rahi M, Murhekar MV.   +54 more
europepmc   +1 more source

A randomized, non-inferiority phase III clinical trial of immunogenicity and safety of 5-dose and 4-dose schedules of a freeze-dried human rabies vaccine (MRC-5 cells) in participants aged 10-60. [PDF]

BMC Infect Dis
Zhao D, Zhao J, Chen X, Yuan L, Wang P, Shi L, Wang Y, Li J, Zhou L, Wu X, Yang S, Gao L.   +11 more
europepmc   +1 more source

Rabies Vaccine for Prophylaxis and Treatment of Rabies: A Narrative Review. [PDF]

Cureus
Kaye AD, Perilloux DM, Field E, Orvin CA, Zaheri SC, Upshaw WC, Behara R, Parker-Actlis TQ, Kaye AM, Ahmadzadeh S, Shekoohi S, Varrassi G.   +11 more
europepmc   +1 more source

Cutaneous Small Vessel Vasculitis Following Anti-Rabies Vaccine. [PDF]

Indian Dermatol Online J
Agrawal I, Relhan V, Sahoo B, Guglani A.
europepmc   +1 more source

Influencing factors and prediction of neutralizing antibodies in post-exposure rabies vaccine recipients. [PDF]

Heliyon
Huang C, Zhang L, Shan X, Tan S, Ye H, Cao C, Zhang L.   +6 more
europepmc   +1 more source

Safety and immunogenicity of an inactivated vero cell-based rabies vaccine (Rabivax-S) in pre-exposure prophylaxis schedule in Vietnam. [PDF]

Clin Exp Vaccine Res
Hung PN, Hung PN, Giang LTH, Anh NT, Anh BDT, Pho DC, Van Hung P.   +6 more
europepmc   +1 more source

Safety and efficacy assessment of an mRNA rabies vaccine in dogs, rodents, and cynomolgus macaques. [PDF]

NPJ Vaccines
Li J, Yu P, Liu Q, Xu L, Chen Y, Li Y, Zhang F, Zhu W, Peng Y.   +8 more
europepmc   +1 more source

Evaluation of the Efficacy of the Vaccine Production Process in Removing Residual Host Cell DNA from the Vero Cell Rabies Vaccine. [PDF]

Vaccines (Basel)
Li J, Pan R, Yue F, Gao T, Wu X, Shi L, Wang Y, Zhao D, Lan Z, Chen H, Ye Q, Cao S.   +11 more
europepmc   +1 more source

Safety and immunogenicity of a single-dose adenovirus-vectored rabies vaccine over 1 year in adults and children in Tanzania: interim data from an ongoing, partly randomised, controlled, phase 1b/2 trial.

Lancet Infect Dis
Ritchie AJ, Hassan O, Urasa N, Apanga PA, Kimathi R, Kalinga WF, Mtaka IM, Lyimo RG, Shabani MM, Orliacq F, Berg A, Xiang Z, Ahmed S, Athuman T, Ertl HCJ, Olotu A, Douglas AD, RAB002 study team.   +17 more
europepmc   +1 more source

Potency, immunogenicity, and efficacy of rabies vaccine: In vitro and in vivo approach. [PDF]

Immun Inflamm Dis
Akter F, Shamimuzzaman M.
europepmc   +1 more source